Pregnane-Oximino-Alkyl-Amino-Ether Compound as a Novel Class of TGR5 Receptor Agonist Exhibiting Antidiabetic and Anti-Dyslipidemic Activities
Conclusion: Compound14b exhibits antidiabetic and anti-dyslipidemic activities through activating the TGR5 receptor system and can be developed as a lead for the management of type II diabetes and related metabolic complications.Pharmacology
Source: Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Bile | Diabetes | Diets | Drugs & Pharmacology | Endocrinology | Genetics | High Fat | Insulin | Liver | Nutrition | Study | Urology & Nephrology